Meningococcal vaccine may reduce gonorrhoea incidence
Griffith Health
A world-first trial for a promising gonorrhoea vaccine will be led by Griffith University’s Institute for Glycomics and the Kirby Institute at UNSW Sydney. The $2.7 million study incorporates five Australian universities and three health districts and providers, and will test whether a meningococcal B vaccine protects against gonorrhoea in gay and bisexual men. “Gonorrhoea […]